Bladder cancer is characterised by the development of abnormal cells in the lining of the bladder.2 There are three main types of bladder cancer:2
Urothelial carcinoma, also known as transitional cell carcinoma(TCC), which develops in the cells of the bladder lining. It is by far the most common type of bladder cancer, accounting for about 90% of all cases.
Squamous cell carcinoma, which begins in squamous cells of the bladder lining, and accounts for 4% of all bladder cancers.
Adenocarcinoma, which begins in glandular cells in the lining of the bladder, and accounts for 2% of all bladder cancers.
Learn more about bladder cancer and research at Roche.
Find related clinical studies
Use our search to find clinical trials on FindRocheTrials associated with Bladder Cancer
Bray et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2018;68:394-424.
In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.